ZURICH, Sept 24 Novartis on Thursday named Harvard Medical School cancer specialist James Bradner as head of biomedical research with a seat on its executive committee as of March 2016.
Bradner succeeds Mark Fishman, who is retiring after a 13-year stint leading the Swiss company's drug discovery and early clinical development efforts.
11:35 Joan Rivers' Fashion Police Has Been Canceled After a 22-year Run15
17:51 Disneyland half-marathon and other runDisney races cancelled in 201823
17:04 CMA Awards 2017: Who are the country music performers and nominees?20
11:50 Accused cop killer defecates, smears feces on face in courtroom20